Marathon Pharmaceuticals has struck a deal to sell its muscular dystrophy treatment to PTC Therapeutics, two weeks after a group of U.S. senators began scrutinizing the steroidal drug’s pricing.
from WSJ.com: US Business http://ift.tt/2mxN7x8
via IFTTT
No comments:
Post a Comment